| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8628900 | Cytokine | 2018 | 8 Pages |
Abstract
These data suggest that fisetin is a good therapeutic drug for the treatment of inflammatory lung diseases, such as COPD, by inhibiting the TNF-α/NF-κB signalling pathway.
Keywords
RT-PCRTNF-R1PKCδPKCIKKTRAF2IL-8IκB kinaseCOPDChronic obstructive pulmonary diseaseChronic obstructive pulmonary disease (COPD)ELISAEnzyme-linked immunosorbent assaytumour necrosis factor-αTNF receptor-associated factor 2TNF-αtransmembraneFisetinGrowth mediumreverse transcription-polymerase chain reactionProtein kinase C
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Seoghyun Lee, Hyunju Ro, Hyun Ju In, Ji-Hee Choi, Mun-Ock Kim, Jinhyuk Lee, Sung-Tae Hong, Su Ui Lee,